Risk of CYP2C19 Phenoconversion in Healthy Volunteers With Rapid, Normal, and Intermediate Predicted Metabolizers' Status
Clinical trial NCT05264142 · UNKNOWN
Trial details
- NCT number
- NCT05264142
- Sponsor
- University Hospital, Geneva
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2023-03-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.